The Smiddy community, have enabled the distribution of over $5 million to cancer research and patient care initiatives at Mater across the most common men’s and women’s cancers (melanoma, breast, ovarian and prostate cancer).
You have enabled us to support a host of other beneficiaries, including Melanoma Patients Australia, and we’re proud to have assisted their efforts to make a tangible difference to so many.
Our long road to fight cancer doesn’t stop now.
Together with you, we’re determined to keep pressing on in 2015 and beyond, to keep leading the way and remaining proud advocates for cancer research in the community. We’re determined to continually challenge ourselves and those in our community to make a difference in this fight and we thank you for your ongoing support to achieve this shared goal.